Tenting Screws Versus Autogenous Ring Block Grafts During Horizontal Ridge Augmentation
Tenting Screws Combined With Particulate Autogenous and Xenogenic Bone Versus Autogenous Ring Block Grafts Combined With Xenogenic Bone During Horizontal Ridge Augmentation
1 other identifier
interventional
20
1 country
1
Brief Summary
After administering local anesthesia,. A full-thickness mucoperiosteal flap will be incised and be reflected to expose the alveolar bone. The dimensions of the defect will be measured using a periodontal probe to determine the appropriate size of the block graft or the quantity of particle bone graft required. In the non screw group, the blocks will be adapted to fit the recipient sites and secured to the alveolar bone using titanium bone fixation screws. Following the placement of the blocks, bovine particles will be applied over the graft and into any remaining gaps between the block and the recipient site, a resorbable collagen membrane (CM) will be shaped and placed over the graft and fixed using subperiosteal sutures. In Tenting screw cases, the screws will be placed in suitable positions and depths, blocks will be crushed into particulates which will then be mixed with equal amount of bovine particles. the mixture will be applied to the recipient site all around the tenting screws a resorbable collagen membrane (CM) will be shaped and placed over the graft and fixed using subperiosteal sutures. The flaps will then be sutured
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 20, 2025
CompletedFirst Posted
Study publicly available on registry
February 25, 2025
CompletedStudy Start
First participant enrolled
March 10, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 27, 2026
CompletedMarch 25, 2025
March 1, 2025
10 months
February 20, 2025
March 21, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Horizontal bone width gain
6months
Study Arms (2)
tenting screw group
EXPERIMENTALnon screw group
ACTIVE COMPARATORInterventions
In Tenting screw cases, the screws will be placed in suitable positions and depths, blocks will be crushed into particulates which will then be mixed with equal amount of bovine particles. the mixture will be applied to the recipient site all around the tenting screws a resorbable collagen membrane (CM) will be shaped and placed over the graft and fixed using subperiosteal sutures.
In the non screw group, the blocks will be adapted to fit the recipient sites and secured to the alveolar bone using titanium bone fixation screws. Following the placement of the blocks, bovine particles will be applied over the graft and into any remaining gaps between the block and the recipient site, a resorbable collagen membrane (CM) will be shaped and placed over the graft and fixed using subperiosteal sutures
Eligibility Criteria
You may qualify if:
- Patient has anterior maxillary horizontal defect less than 4mm in the alveolar ridge and (classified as class III or IV atrophy according to Cawood and Howell classification). (Cawood \& Howell, 1988require horizontal bone augmentation in anterior maxilla before dental implant placement and in need of an implant-supported restoration in at least one site,
- Adult individuals aged 18 years or older
- Satisfactory oral hygiene,
- No previous history of bone augmentation procedures at the site to be treated in the study,
- The ability to comprehend and provide informed consent.
You may not qualify if:
- Uncontrolled systemic disorders,
- Prior irradiation in the head and neck region,
- Immunosuppression or compromised immune system,
- Oral disorders such as lichen planus, ongoing or recent treatment with intravenous amino- bisphosphonates, untreated periodontitis,
- Poor oral hygiene and motivation,
- Parafunctional habits, pregnancy or lactation,
- Substance abuse involving drugs or alcohol, psychiatric disorders, a history (within the last 3 months) of regular use of smokeless chewing tobacco, smoking a pipe, cigar, or more than 10 cigarettes per day, acute or chronic infection or inflammation in the area, or
- Extraction with less than 3 months of healing.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nahda University
Beni-seuf, 2711860, Egypt
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- associate professor
Study Record Dates
First Submitted
February 20, 2025
First Posted
February 25, 2025
Study Start
March 10, 2025
Primary Completion
January 1, 2026
Study Completion
February 27, 2026
Last Updated
March 25, 2025
Record last verified: 2025-03